← Leaderboards
John C Somberg
Academic Pharmaceuticals, Inc.
$766,806
Attributed
$766,806
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $311.7K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$766,806 · 6
By mechanism
R43$766,806 · 6
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsAnimalsVentricular TachycardiaPreparationLifeGrantBaseCanis FamiliarisAnimal ModelReportingTorsades De PointesArrhythmiaDoseAdultCardiacElectrocardiogramEvaluationAnalgesicsDrug FormulationsDrug KineticsFemaleChildhoodAmiodaroneClinical Research
Grant awards (6)
Developing a Parenteral Formulation of Metolazone$158,460
R43 · FY2019 · DK · contact PI
Soestolol: A potentially short acting Type III anti-arrhythmic$153,260
R43 · FY2019 · HL · contact PI
A Safer Cardiac, Abuse Deterrent Formulation of Methadone$149,980
R43 · FY2017 · HL · contact PI
Reducing Methadone's Arrhythmic potential$102,910
R43 · FY2010 · HL · contact PI
Pediatric Acceptable Formulation of Amiodarone$100,188
R43 · FY2009 · HL · contact PI
Digoxin Chiral Isolates as Improved Pharmaceuticals$102,008
R43 · FY2005 · HL